Anu Natarajan, PhD, MBASenior Associate Director
Anu joined the BBA, OTD in 2018 and manages the ongoing and upcoming Blavatnik Biomedical Accelerator funded programs. Prior to joining Harvard, Anu was the Director of Business Development at EpiDestiny - a company that focused on clinical programs in rare diseases in hematology-oncology. As a Senior Manager, Company Creation at Innovate Calgary and as an independent Consultant, she has led the business strategy development for several early-stage companies across Canada, the US and UK. Anu holds a PhD from the University of Vienna, Austria (Summa cum Laude), MBA in Management of Technology from Simon Fraser University, Canada and Masters in Life Sciences from Bharathidasan University, India.